1.
|
12 p, 608.0 KB |
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk
/
Gatell, José Mª (Hospital Clínic i Provincial de Barcelona) ;
Assoumou, Lambert (UPMC Univ Paris 06) ;
Moyle, Graeme (St Chelsea and Westminster Hospital) ;
Waters, Laura (Mortimer Market Center) ;
Johnson, Margaret (Royal Free Hospital) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Fox, Julie (Guys and St. Thomas Hospital) ;
Martinez, Esteban (Hospital Clínic i Provincial de Barcelona) ;
Stellbrink, Hans-Jürgen (ICH Study Centrum) ;
Guaraldi, Giovanni (University of Modena and Reggio Emilia) ;
Masia, Mar (Hospital General Universitario de Elche) ;
Gompels, Marl (Southmead Hospital) ;
De Wit, Stephane (Université Libre de Bruxelles) ;
Florence, Eric (Institute of Tropical Medicine) ;
Esser, Stefan (Universitatsklinikum) ;
Raffi, François (CHU de Nantes) ;
Pozniak, Anton L. (St Chelsea and Westminster Hospital) ;
Universitat Autònoma de Barcelona
To compare the efficacy, safety, and impact on lipid fractions of switching from a ritonavir-boosted protease inhibitor (PI/r) to a dolutegravir (DTG) regimen. HIV type 1-infected adults more than 50 years or with a Framingham score more than 10% were eligible if plasma HIV RNA less than 50 copies per ml for at least 24 weeks while on a PI/r regimen. [...]
2017 - 10.1097/QAD.0000000000001675
AIDS, Vol. 31 Núm. 18 (28 2017) , p. 2503-2514
|
|
2.
|
20 p, 846.7 KB |
Moderate beer intake and cardiovascular health in overweight individuals
/
Padró, Teresa (Institut d'Investigació Bomèdica Sant Pau) ;
Muñoz-García, Natàlia (Institut d'Investigació Biomèdica Sant Pau) ;
Vilahur, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Chagas, Patricia (Universidade Federal de Santa Maria) ;
Deyà, Alba (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Antonijoan Arbós, Rosa Ma (Institut d'Investigació Biomèdica Sant Pau) ;
Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Consistent epidemiological evidence indicates that low-to-moderate alcohol consumption is inversely associated with cardiovascular event presentation, while high levels of alcohol intake are associated to increased cardiovascular risk. [...]
2018 - 10.3390/nu10091237
Nutrients, Vol. 10 Núm. 9 (may 2018) , p. 1237
|
|
3.
|
10 p, 1010.2 KB |
A functional virgin olive oil enriched with olive oil and thyme phenolic compounds improves the expression of cholesterol efflux-related genes : A randomized, crossover, controlled trial
/
Farràs Mañé, Marta (Institut d'Investigació Biomèdica Sant Pau) ;
Arranz, Sara (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Carrión, Sílvia (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Subirana, Isaac (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Muñoz Aguayo, Daniel (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Blanchart, Gemma (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Kool, Marjon (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Solà, Rosa (Hospital Universitari Sant Joan de Reus (Tarragona)) ;
Motilva, María José (Instituto de Ciencias de la Vid y el Vino) ;
Escolà-Gil, Joan Carles (Institut d'Investigació Biomèdica Sant Pau) ;
Rubió, Laura (Universitat de Lleida) ;
Fernández-Castillejo, Sara (Institut d'Investigació Sanitària Pere Virgili) ;
Pedret, Anna (Institut d'Investigació Sanitària Pere Virgili) ;
Estruch, Ramón (Hospital Clínic i Provincial de Barcelona) ;
Covas Planells, Maria Isabel (NUPROAS HB) ;
Fitó, Montserrat (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Hernáez, Álvaro (CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN)) ;
Castañer, Olga (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Universitat Autònoma de Barcelona
The consumption of antioxidant-rich foods such as virgin olive oil (VOO) promotes high-density lipoprotein (HDL) anti-atherogenic capacities. Intake of functional VOOs (enriched with olive/thyme phenolic compounds (PCs)) also improves HDL functions, but the gene expression changes behind these benefits are not fully understood. [...]
2019 - 10.3390/nu11081732
Nutrients, Vol. 11 Núm. 8 (2019) , p. 1732
|
|
4.
|
|
5.
|
19 p, 11.0 MB |
Annexin A6 modulates TBC1D15/Rab7/StARD3 axis to control endosomal cholesterol export in NPC1 cells
/
Meneses-Salas, E. (Centre de Recerca Biomèdica CELLEX) ;
García-Melero, A. (Universitat de Barcelona) ;
Kanerva, K. (Minerva Foundation Institute for Medical Research) ;
Blanco-Muñoz, P. (Centre de Recerca Biomèdica CELLEX) ;
Morales-Paytuvi, F. (Centre de Recerca Biomèdica CELLEX) ;
Bonjoch, J. (Centre de Recerca Biomèdica CELLEX) ;
Casas, J. (Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)) ;
Egert, A. (University of Sydney) ;
Beevi, S.S. (University of Sydney) ;
Jose, J. (University of Sydney) ;
Llorente-Cortes, Vicenta (Institut d'Investigació Biomèdica Sant Pau) ;
Rye, K.A. (University of New South Wales) ;
Heeren, J. (University Medical Center Hamburg-Eppendorf) ;
Lu, A. (Stanford University School of Medicine) ;
Pol, A. (Institució Catalana de Recerca i Estudis Avançats) ;
Tebar, F. (Centre de Recerca Biomèdica CELLEX) ;
Ikonen, E. (Minerva Foundation Institute for Medical Research) ;
Grewal, T. (University of Sydney) ;
Enrich, C. (Centre de Recerca Biomèdica CELLEX) ;
Rentero, C. (Centre de Recerca Biomèdica CELLEX) ;
Universitat Autònoma de Barcelona
Cholesterol accumulation in late endosomes is a prevailing phenotype of Niemann-Pick type C1 (NPC1) mutant cells. Likewise, annexin A6 (AnxA6) overexpression induces a phenotype reminiscent of NPC1 mutant cells. [...]
2020 - 10.1007/s00018-019-03330-y
Cellular and Molecular Life Sciences, Vol. 77 Núm. 14 (january 2020) , p. 2839-2857
|
|
6.
|
7 p, 2.1 MB |
NR4A1 Deletion in Marginal Zone B Cells Exacerbates Atherosclerosis in Mice - Brief Report
/
Nus Chimeno, Meritxell Edurne (Division of Cardiovascular Medicine. Department of Medicine. University of Cambridge) ;
Basatemur, G. (University of Cambridge) ;
Galán, María (Institut d'Investigació Biomèdica Sant Pau) ;
Cros-Brunsó, Laia (University of Cambridge) ;
Zhao, T.X. (University of Cambridge) ;
Masters, L. (University of Cambridge) ;
Harrison, J. (University of Cambridge) ;
Figg, N. (University of Cambridge) ;
Tsiantoulas, D. (Medical University of Vienna) ;
Geissmann, F. (Memorial Sloan Kettering Cancer Centre) ;
Binder, C.J. (Medical University of Vienna) ;
Sage, A.P. (University of Cambridge) ;
Mallat, Ziad (Paris Cardiovascular Research Center) ;
Universitat Autònoma de Barcelona
NR4A orphan receptors have been well studied in vascular and myeloid cells where they play important roles in the regulation of inflammation in atherosclerosis. NR4A1 (nerve growth factor IB) is among the most highly induced transcription factors in B cells following BCR (B-cell receptor) stimulation. [...]
2020 - 10.1161/ATVBAHA.120.314607
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 40 Núm. 11 (january 2020) , p. 2598-2604
|
|
7.
|
|
8.
|
12 p, 648.4 KB |
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
/
Bittner, Vera A. (University of Alabama at Birmingham) ;
Szarek, Michael (State University of New York) ;
Aylward, Philip (South Australian Health and Medical Research Institute) ;
Bhatt, Deepak L. (Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School) ;
Díaz, Rafaël J. (Instituto Cardiovascular de Rosario) ;
Edelberg, Jay M. (Sanofi) ;
Fras, Zlatko (University of Ljubljana) ;
Goodman, Shaun G. (University of Toronto) ;
Halvorsen, Sigrun (University of Oslo) ;
Hanotin, Corinne (Sanofi) ;
Harrington, Robert A. (Stanford University) ;
Jukema, J. Wouter (Leiden University Medical Center) ;
Loizeau, Virginie (Sanofi) ;
Moriarty, Patrick Maurice (University of Kansas Medical Center) ;
Moryusef, Angèle (Sanofi) ;
Pordy, Robert (Regeneron Pharmaceuticals Inc.) ;
Roe, Matthew T. (Duke University School of Medicine) ;
Sinnaeve, Peter (University of Leuven) ;
Tsimikas, Sotirios (University of California San Diego) ;
Vogel, Robert A. (University of Colorado School of Medicine) ;
White, Harvey D. (Green Lane Cardiovascular Services Auckland City Hospital) ;
Zahger, Doron (Soroka University Medical Center) ;
Zeiher, Andreas Michael (Goethe University) ;
Steg, Philippe Gabriel (Royal Brompton Hospital (Londres)) ;
Schwartz, Gregory G. (University of Colorado School of Medicine) ;
Matas Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ;
Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Coca Payeras, Antonio (Hospital Clínic i Provincial de Barcelona) ;
Cequier, Ángel (Hospital Universitari de Bellvitge) ;
García-Dorado, David (Hospital Universitari Vall d'Hebron) ;
Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ;
Universitat Autònoma de Barcelona
Lipoprotein(a) concentration is associated with cardiovascular events. Alirocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, lowers lipoprotein(a) and low-density lipoprotein cholesterol (LDL-C). [...]
2020 - 10.1016/j.jacc.2019.10.057
Journal of the American College of Cardiology, Vol. 75 Núm. 2 (21 2020) , p. 133-144
|
|
9.
|
15 p, 671.9 KB |
Vitamin D3 Supplementation in Overweight/Obese Pregnant Women : No Effects on the Maternal or Fetal Lipid Profile and Body Fat Distribution-A Secondary Analysis of the Multicentric, Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes Prevention Trial (DALI)
/
Harreiter, Jürgen (Medical University of Vienna) ;
Mendoza, Lilian Cristina (Institut d'Investigació Biomèdica Sant Pau) ;
Simmons, David (Western Sydney University. Macarthur Clinical School) ;
Desoye, Gernot (Medical University of Graz) ;
Devlieger, Roland (Department of Obstetrics. Gynecology and Fertility. GZA Sint-Augustinus) ;
Galjaard, Sander (University Medical Centre Rotterdam. Department of Obstetrics and Gynaecology) ;
Damm, Peter (University of Copenhagen. Department of Clinical Medicine) ;
Mathiesen, Elisabeth R. (University of Copenhagen. Department of Clinical Medicine) ;
Jensen, Dorte M (University of Southern Denmark. Department of Clinical Research) ;
Andersen, Lise-Lotte (University of Southern Denmark. Department of Clinical Research) ;
Dunne, Fidelma (Clinical Research Facility (CRF) and National University of Ireland) ;
Lapolla, Annunziata (Department of Medicine. Universita Degli Studi di Padova) ;
Dalfra, Maria Grazia (Department of Medicine. Universita Degli Studi di Padova) ;
Bertolotto, Alessandra (Azienda Ospedaliero-Universitaria Pisana) ;
Wender-Ozegowska, Ewa (Poznan University of Medical Sciences) ;
Zawiejska, Agnieszka (Poznan University of Medical Sciences) ;
Hill, David J. (Lawson Health Research Institute) ;
Jelsma, Judith G. M (Amsterdam Public Health Research Institute) ;
Snoek, Frank J. (Amsterdam Public Health Research Institute) ;
Worda, Christof (Medical University of Vienna) ;
Bancher-Todesca, Dagmar (Medical University of Vienna) ;
van Poppel, M.N.M. (University of Graz. Institute of Human Movement Science) ;
Corcoy i Pla, Rosa (Institut d'Investigació Biomèdica Sant Pau) ;
Kautzky-Willer, Alexandra (Gender Institute)
Vitamin D deficiency is a common finding in overweight/obese pregnant women and is associated with increased risk for adverse pregnancy outcome. Both maternal vitamin D deficiency and maternal obesity contribute to metabolic derangements in pregnancy. [...]
2022 - 10.3390/nu14183781
Nutrients, Vol. 14 Núm. 18 (september 2022) , p. 3781
|
|
10.
|
9 p, 4.2 MB |
MiR-125b downregulates macrophage scavenger receptor type B1 and reverse cholesterol transport
/
Hueso, Miguel (Institut d'Investigació Biomèdica de Bellvitge) ;
Griñán, Raquel (Institut d'Investigació Biomèdica Sant Pau) ;
Mallen, Adrián (Institut d'Investigació Biomèdica de Bellvitge) ;
Navarro, Estanislao (Institut d'Investigació Biomèdica de Bellvitge) ;
Purqueras, Elvira (Institut d'Investigació Biomèdica de Bellvitge) ;
Gomá, Montse (Institut d'Investigació Biomèdica de Bellvitge) ;
Sbraga, Fabritzio (Institut d'Investigació Biomèdica de Bellvitge) ;
Blasco-Lucas, Arnau (Hospital Universitari de Bellvitge) ;
Revilla, Giovanna (Institut d'Investigació Biomèdica Sant Pau) ;
Santos, David (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ;
Canyelles, Marina (Institut d'Investigació Biomèdica Sant Pau) ;
Julve i Gil, Josep (Institut d'Investigació Biomèdica Sant Pau) ;
Escolà-Gil, Joan Carles (Institut d'Investigació Biomèdica Sant Pau) ;
Rotllan, Noemi (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Objective: To determine whether miR-125b regulates cholesterol efflux in vivo and in vitro through the regulation of scavenger receptor type B1 (SR-B1). Approach and results: We demonstrated that miR-125b is up-regulated in the human aortas of patients with CAD and is located in macrophages and vascular smooth muscle cells (VSMCs). [...]
2022 - 10.1016/j.biopha.2021.112596
Biomedicine & pharmacotherapy, Vol. 146 (february 2022) , p. 112596
|
|